News | bit.bio (3)

bit.bio wins Biotech Company of the Year at the Cambridge Independent Science and Technology awards

bit.bio wins Biotech Company of the Year at the Cambridge Independent Science and Technology awards

Apr 16, 2021

Published by Cambridge Independent

Meet the company reprogramming the future of synthetic biology

Meet the company reprogramming the future of synthetic biology

Apr 14, 2021

Published by Forbes

Sitting down with… bit.bio

Sitting down with… bit.bio

Apr 9, 2021

Published by DDW journal online

Podcast: Dr Mark Kotter speaks about what’s behind the company’s mission of ‘coding cells for health’ – episode 1 of a Pint of Science mini-series

Podcast: Dr Mark Kotter speaks about what’s behind the company’s mission of ‘coding cells for health’ – episode 1 of a Pint of Science mini-series

Apr 7, 2021

Published by bit.bio

Q&A with Dr Mark Kotter: Transforming drug discovery and medical research

Q&A with Dr Mark Kotter: Transforming drug discovery and medical research

Apr 6, 2021

Published by bit.bio

bit.bio CEO Dr Mark Kotter speaking about challenging biology at the TEDxCambridgeUniversity ‘Untangling networks’ event

bit.bio CEO Dr Mark Kotter speaking about challenging biology at the TEDxCambridgeUniversity ‘Untangling networks’ event

Mar 26, 2021

Published by bit.bio

Cultivated meat, cell therapies and opti-ox™ – the technology that underpins them both

Cultivated meat, cell therapies and opti-ox™ – the technology that underpins them both

Mar 23, 2021

Published by bit.bio

Leading clinical immunotherapies developer Ramy Ibrahim joins bit.bio as Chief Medical Officer

Leading clinical immunotherapies developer Ramy Ibrahim joins bit.bio as Chief Medical Officer

Feb 11, 2021

Published by bit.bio

bit.bio CEO discusses opti-ox™ technology and the work of bit.bio on BBC Click

bit.bio CEO discusses opti-ox™ technology and the work of bit.bio on BBC Click

Feb 6, 2021

Published by BBC Click

Page 3 of 5 « 1 2 3 4 5 »